NCT04389060

Brief Summary

This study investigated if elevated BP and aortic stiffness characterized in obese individuals are attenuated following acute grape seed extract supplementation. It is hypothesized that acute dietary supplementation with grape seed extract attenuates aortic stiffness, systolic blood pressure, diastolic blood pressure, mean arterial pressure, and total peripheral resistance and these effects are partially due to reductions in peripheral vasoconstriction

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 8, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 15, 2020

Completed
Last Updated

May 15, 2020

Status Verified

May 1, 2020

Enrollment Period

1 year

First QC Date

May 8, 2020

Last Update Submit

May 11, 2020

Conditions

Outcome Measures

Primary Outcomes (7)

  • change in heart rate

    beats per minute

    2 hours after each supplementation

  • change in stroke volume

    volume per stroke

    2 hours after each supplementation

  • change in cardiac output

    total volume for a minute

    2 hours after each supplementation

  • change in systolic blood pressure

    pressure exerted during contraction

    2 hours after each supplementation

  • change in diastolic blood pressure

    pressure exerted during relaxation

    2 hours after each supplementation

  • change in mean arterial pressure

    One reported pressure (systolic blood pressure-diastolic blood pressure)/3 + diastolic blood pressure

    2 hours after each supplementation

  • change in total peripheral resistance

    One reported value (mean arterial pressure/cardiac output)

    2 hours after each supplementation

Study Arms (2)

GSE group

ACTIVE COMPARATOR

Subjects took a single dose of 600 mg GSE in capsule form through ingestion 2 hours prior to testing

Dietary Supplement: Grape seed extract

Placebo group

PLACEBO COMPARATOR

Subjects took a single dose of 600 mg starch in capsule form through ingestion 2 hours prior to testing

Dietary Supplement: Grape seed extract

Interventions

Grape seed extractDIETARY_SUPPLEMENT

Two capsule grape seed extract (total 600 mg)

GSE groupPlacebo group

Eligibility Criteria

Age18 Years - 29 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Obesity: body mass index (\>30), Normal body weight: body mass index (25-29)

You may not qualify if:

  • cardiovascular diseases or consume any antihypertensive medication or supplementation that can affect blood pressure or aortic stiffness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

California Baptist University

Riverside, California, 92504, United States

Location

MeSH Terms

Conditions

Obesity

Interventions

Grape Seed Extract

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Plant ExtractsPlant PreparationsBiological ProductsComplex MixturesPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double blind, cross-over design
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 8, 2020

First Posted

May 15, 2020

Study Start

March 1, 2019

Primary Completion

March 1, 2020

Study Completion

March 1, 2020

Last Updated

May 15, 2020

Record last verified: 2020-05

Locations